Very strong sales and earnings increase in the third quarter 2025

Nexus AG: Very strong sales and earnings increase in the third quarter 2025

Donaueschingen, 04/11/2025: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its sales by approx. 10% and EBIT by approx. 16% in the first nine months of 2025. As a result, the continually positive development of sales and earnings of the last years could be continued.

Sales improved from KEUR 190,805 to KEUR 209,671 (+9.9%) in the first nine months 2025. The international share of total business volume was 39.6% (9M-2024: 43.7%) and amounted to KEUR 83,048 compared to KEUR 83,382 (9M-2024).

The EBITA rose very sharply by 15.9% from KEUR 31,743 (9M-2024) to KEUR 36,798. Consolidated earnings before interest and taxes (EBIT) rosed sharp by 15.8% to KEUR 31,484 (9M-2024: KEUR 27,179). The consolidated surplus increased by 14.0% to KEUR 23,094 (9M-2024: KEUR 20,267) and EBITDA increased by 12.4% to KEUR 45,928 (9M-2024 KEUR 40,856).

As of 30/09/2025, the company had cash resources at its disposal in the amount of KEUR 126,674 (31/12/2024: KEUR 114,038). Nexus AG had equity capital amounting to KEUR 304,858 as of 30/09/2025 (31/12/2024: KEUR 282,958). Consequently, the equity capital rate is 62.3 % (31/12/2024: 64.6 %)

Downloads

You might also be interested in

    • NEXUS-Gruppe

    VERY STRONG REVENUES AND EARNINGS INCREASE IN 2022

    Donaueschingen, 07/03/2023: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its revenues by 11.1% and EBIT by 15.2% in the fiscal year 2022. As a result, the continually positive development of revenues and earnings of the last two decades could be continued.

    • NEXUS-Gruppe

    Strong sales and earnings increase in the first half-year 2023

    Donaueschingen, 15 August 2023: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its sales by approx. 12% and EBT by 23% in the first six months of 2023. As a result, the continually positive development of sales and earnings of the last years could be continued.

    • NEXUS-Gruppe

    VERY STRONG SALES AND EARNINGS INCREASE IN THE FIRST QUARTER 2023

    Donaueschingen, 16/05/2023: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its sales by 11% and EBIT by approx. 28% in the first three months of 2023. As a result, the continually positive development of sales and earnings of the last years could be continued.

    • NEXUS-Gruppe

    Very strong sales and earnings increase in the third quarter 2023

    Donaueschingen, 07/11/2023: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its sales by 14% and EBT by approx. 33% in the first nine months of 2023. As a result, the continually positive development of sales and earnings of the last years could be continued.

    • NEXUS-Gruppe

    VERY STRONG REVENUES AND EARNINGS INCREASE IN 2023

    Donaueschingen, 05/03/2024: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its revenues by 15.5% and EBT by 21% in the fiscal year 2023. As a result, the continually positive development of revenues and earnings of the last two decades could be continued.

Do you need help? We are happy to advise you.
Contact Mail
X
Version: 02193-040
Lightbulb
What are you looking for? Fachbereiche, Experten, Behandlungsschwerpunkte und Standorte
Nicht das gewünschte Ergebnis? Nutzen Sie die globale Suche. Zur Suche